Alexion Pharmaceuticals, Inc. — H-1B Visa Sponsorship
Alexion Pharmaceuticals, Inc. H-1B Sponsorship Analysis: FY2025 Focus
Alexion Pharmaceuticals, Inc. H-1B Visa Sponsorship Summary
| Metric | Value |
|---|---|
| Total H-1B Petitions | 6 |
| Approval Rate | 100% |
| Average Salary | $136,625 |
| Salary Range | $96,900 - $164,815 |
| Top Job Title | Senior Engineer II, Injectable Drug Product Development |
| Primary Location | Connecticut |
Browse by Fiscal Year
About Alexion Pharmaceuticals, Inc.'s H-1B Sponsorship
Alexion Pharmaceuticals, Inc. has filed 6 H-1B visa petitions with a 100.0% approval rate. Alexion Pharmaceuticals, Inc. shows a consistent sponsorship pattern, with all six H-1B visas filed in FY2025. The company sponsors a range of roles, from scientific research to data analytics, indicating diverse talent needs. All sponsorships are concentrated in Connecticut and Massachusetts, suggesting a focus on specific R&D hubs.
Key Insights
- All six visa filings are for FY2025, indicating a proactive and current hiring strategy.
- The job titles suggest a strong emphasis on scientific and technical roles, particularly in drug development and analytics.
- The distribution of sponsorships between CT and MA (3 each) points to a balanced investment in these two key states.
- The average salary offered is $136,625, which is competitive within the pharmaceutical industry.
- The highest salary offered ($164,815) is for a Senior Engineer II role, reflecting the value placed on experienced technical talent.
- The lowest salary offered ($96,900) is for a Development Scientist III role, which might indicate a junior level or a specific niche within the role.
- The company sponsors multiple positions within the same job titles, such as 'Senior Engineer II, Injectable Drug Product Development', suggesting team expansion or multiple openings.
- No H-1B petitions were denied, withdrawn, or are pending, indicating a high success rate for their applications.
Expert Analysis
Peer Comparison: Alexion Pharmaceuticals, Inc. demonstrates a stable and successful H-1B sponsorship approach, comparable to other large pharmaceutical companies.
Negotiation Tip: Given the competitive salaries and high success rate, candidates may have some leverage to negotiate based on experience and market rates.
Similar Employers
Filing Statistics
| Total Filings | 6 |
| Certified | 6 |
| Approval Rate | 100% |
| Average Salary | $136,625 |
| Median Salary | $145,000 |
| Salary Range | $96,900 – $164,815 |
| 10th Percentile Salary | $96,900 |
| 25th Percentile Salary | $128,238 |
| 75th Percentile Salary | $145,000 |
| 90th Percentile Salary | $164,815 |
| Industry | Manufacturing (NAICS: 32) |
| Sponsor Grade | B — Score: 83/100 (high confidence) |
USCIS Petition Outcomes for Alexion Pharmaceuticals, Inc.
Actual H-1B visa petition results from USCIS (FY2015–2023). This shows whether petitions were approved or denied by immigration — separate from DOL labor condition filings above.
| Fiscal Year | Approvals | Denials | Approval Rate |
|---|---|---|---|
| 2015 | 0 | 0 | N/A |
| 2016 | 0 | 0 | N/A |
| 2017 | 0 | 0 | N/A |
| 2018 | 0 | 0 | N/A |
| 2019 | 0 | 0 | N/A |
| 2020 | 13 | 1 | 92.9% |
| 2021 | 52 | 2 | 96.3% |
| 2022 | 20 | 1 | 95.2% |
| 2023 | 13 | 1 | 92.9% |
Green Card (PERM) Sponsorship by Alexion Pharmaceuticals, Inc.
PERM labor certification data shows whether Alexion Pharmaceuticals, Inc. sponsors employees for green cards (permanent residency). This data is from DOL PERM disclosure files (FY2020–2026).
| Year | Certified | Denied | Total | Rate |
|---|---|---|---|---|
| 2019 | 1 | 0 | 1 | 100% |
| 2020 | 2 | 0 | 3 | 66.7% |
| 2021 | 4 | 0 | 4 | 100% |
| 2022 | 0 | 0 | 1 | 0% |
| 2023 | 1 | 0 | 2 | 50% |
| 2024 | 2 | 0 | 2 | 100% |
Top PERM Job Titles
| Job Title | Filings |
|---|---|
| Associate Director, US Sales Training & Development Metabolics | 2 |
| Associate Director, Biostatistics | 2 |
| Associate Director, New Products | 1 |
| Associate Director, U.S. Business Analytics | 1 |
| Senior Manager - Business Intelligence | 1 |
Top Countries of Origin (PERM)
| Country | Filings |
|---|---|
| INDIA | 7 |
| CHINA | 3 |
| RUSSIA | 2 |
| FRANCE | 1 |
Salary Distribution
| 10th Percentile | $96,900 |
| 25th Percentile | $115,000 |
| Median (50th) | $143,777 |
| 75th Percentile | $165,737 |
| 90th Percentile | $212,180 |
| Average | $146,014 |
| Sample Size | 49 |
Prevailing Wage Comparison
Processing Time
Workforce Insights
Filing Trend by Year
| Year | Filings | Avg Salary |
|---|---|---|
| FY2025 | 6 | N/A |
Top Job Titles at Alexion Pharmaceuticals, Inc.
| Job Title | Filings |
|---|---|
| Senior Engineer II, Injectable Drug Product Development | 2 |
| Senior Engineer, Biologics Drug Substance Tech Transfer | 1 |
| Development Scientist II, Analytical Dev & Clinical QC | 1 |
| Senior Manager, Data Analytics and Insights | 1 |
| Associate Scientist III, Upstream Process Development | 1 |
Work Locations
| State | Filings |
|---|---|
| Connecticut | 3 |
| Massachusetts | 3 |
Visa Classes
Frequently Asked Questions about Alexion Pharmaceuticals, Inc.
Does Alexion Pharmaceuticals, Inc. sponsor H-1B visas?
Yes, Alexion Pharmaceuticals, Inc. actively sponsors H-1B visas. They have filed 6 H-1B petitions with a 100.0% approval rate.
What is the average H-1B salary at Alexion Pharmaceuticals, Inc.?
The average H-1B salary at Alexion Pharmaceuticals, Inc. is $136,625, with a median of $145,000. Salaries range from $96,900 to $164,815 across 6 filings.
What is Alexion Pharmaceuticals, Inc.'s H-1B approval rate?
Alexion Pharmaceuticals, Inc.'s H-1B approval rate is 100.0%. Out of 6 total filings, 6 were certified, 0 denied, and 0 withdrawn.
How many H-1B visas does Alexion Pharmaceuticals, Inc. file per year?
Alexion Pharmaceuticals, Inc. has filed H-1B petitions across 1 fiscal years. Recent volumes: FY2025: 6.
What jobs does Alexion Pharmaceuticals, Inc. sponsor H-1B visas for?
The most common H-1B job titles at Alexion Pharmaceuticals, Inc. are: Senior Engineer II, Injectable Drug Product Development, Senior Engineer, Biologics Drug Substance Tech Transfer, Development Scientist II, Analytical Dev & Clinical QC, Senior Manager, Data Analytics and Insights, Associate Scientist III, Upstream Process Development. The top role, Senior Engineer II, Injectable Drug Product Development, accounts for 2 filings.
Where are Alexion Pharmaceuticals, Inc.'s H-1B jobs located?
Alexion Pharmaceuticals, Inc.'s H-1B positions are primarily located in Connecticut (3 filings), Massachusetts (3 filings).
Is Alexion Pharmaceuticals, Inc. increasing or decreasing H-1B hiring?
Alexion Pharmaceuticals, Inc. has filed 6 H-1B petitions total. Insufficient year-over-year data to determine a trend.
What is Alexion Pharmaceuticals, Inc.'s H-1B denial rate?
Alexion Pharmaceuticals, Inc. has a 0.0% denial rate across 6 filings (0 denied). They have zero denials on record.
What is the salary range for H-1B positions at Alexion Pharmaceuticals, Inc.?
H-1B salaries at Alexion Pharmaceuticals, Inc. range from $96,900 to $164,815. The 25th percentile is $128,238, median is $145,000, and 75th percentile is $145,000.
Is Alexion Pharmaceuticals, Inc. a good H-1B sponsor?
Alexion Pharmaceuticals, Inc. has a 100.0% approval rate with 6 filings. All six visa filings are for FY2025, indicating a proactive and current hiring strategy.
How does Alexion Pharmaceuticals, Inc.'s H-1B salary compare to market?
Alexion Pharmaceuticals, Inc. pays an average of $136,625 for H-1B positions. The job titles suggest a strong emphasis on scientific and technical roles, particularly in drug development and analytics.
How does Alexion Pharmaceuticals, Inc. compare to Pfizer Inc. for H-1B?
Alexion Pharmaceuticals, Inc. demonstrates a stable and successful H-1B sponsorship approach, comparable to other large pharmaceutical companies.
What should I negotiate for an H-1B position at Alexion Pharmaceuticals, Inc.?
Given the competitive salaries and high success rate, candidates may have some leverage to negotiate based on experience and market rates.
What should H-1B candidates know about Alexion Pharmaceuticals, Inc.?
The distribution of sponsorships between CT and MA (3 each) points to a balanced investment in these two key states.